Form 4 Filing for Context Therapeutics Inc. - Pasternak Andy

This filing details a Form 4 submission for Context Therapeutics Inc. (CNTX) concerning transactions by reporting owner Andy Pasternak. On June 24, 2026, Pasternak was granted 45,000 stock options with a right to buy at a price of $0.0 per share. These options are exercisable and vest on the earlier of June 24, 2027, or the Issuer's 2027 annual meeting of stockholders, provided continued service. The options have an expiration date of June 23, 2036. Pasternak, who is a director at Context Therapeutics Inc., acquired these options, bringing his post-transaction total to 45,000 shares. The underlying security for these options is the company's Common Stock.